Bloomlife has filed a notice of an exempt offering of securities to raise $14,886,953.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Bloomlife is raising up to $14,886,953.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Eric Dy played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Bloomlife
Bloomlife is an award winning womens health company solving the most significant yet underserved global challenges today in maternal health. We are redefining the way prenatal care is delivered by combining connected devices with cloud based data analytics to improve access to care, empower women, and provide clinicians with information to more effectively screen and manage pregnancy complications. Our goal is to become the leading provider of remote care for expectant women globally. Bloomlifes approach to managing high risk pregnancies allows obstetricians to more easily screen maternal and fetal risk, educate the patient, and quickly access high risk specialists regardless of a patients geography. Our solution represents a marked shift from the way high risk pregnancies have been historically assessed using frequent in person appointments, paper logs, and long referral times.
To learn more about Bloomlife, visit http://www.bloom-life.com/
Bloomlife Linkedin Page: https://www.linkedin.com/company/bloom-technologies/
Contact:
Eric Dy, Chief Executive Officer
415-215-4251
https://www.linkedin.com/in/ericdy/
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.